Clinical Trials Browser

Phase 3 × OTHER × Triptorelin Pamoate × Clear all

NCT04513717 2026-01-14

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04181203 2025-07-30

CARLHA-2

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT00667069 2025-06-05

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT05781217 2023-11-18

URONCOR 06-24

Phase 3 Recruiting

Prostatic Neoplasms

NCT05328258 2023-10-27

ProFertil

Phase 3 Recruiting

LymphoidSarcoma

Lymphoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT05019846 2023-04-18

SPA

Phase 3 Recruiting

Prostatic Neoplasms

NCT00412022 2023-03-24

HOBOE

Phase 3 Unknown

Breast Neoplasms

NCT00104741 2021-02-21

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT01402336 2017-10-10

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

Phase 3 Completed

Infertility, Polycystic Ovary Syndrome